President Joe Biden will issue an executive order Friday directing HHS to support price transparency rules issued by the Trump administration and telling the Federal Trade Commission to prioritize hospital consolidation in its enforcement efforts.
The order will broadly focuses on “promoting competition” in America, and in the healthcare sector, President Biden calls for action on consolidation, drug pricing and price transparency at hospitals.
“Hospital consolidation has left many areas, especially rural communities, without good options for convenient and affordable healthcare service,” reads a fact sheet issued by the White House.
The order will “underscore that hospital mergers can be harmful to patients and encourages the Justice Department and FTC to review and revise their merger guidelines to ensure patients are not harmed,” the White House says.
Biden will also direct HHS to support existing rules issued by the Trump administration and loathed by hospital officials that require they post prices online.
The order also calls for a number of actions on drug pricing, including directing the FDA to work with states on importing prescription drugs from Canada—another proposal pursued by the Trump administration—and encouraging the FTC to ban “pay for delay” tactics that brand-name drug companies use to keep competition out of the market.
Story in Progress.